 ENCINITAS, Calif., March 07, 2022 GLOBE NEWSWIRE -- Ventyx Biosciences, Inc. Nasdaq: VTYX Ventyx or the Company, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders, announced today that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview at the Barclays Global Healthcare Conference being held March 15-17, 2022. 